Last reviewed · How we verify

NCT03217539: WE

The Swedish Two-County Trial of Mammography Screening

Completed NA Last updated 7 February 2018
What this trial tests

NA trial testing Imaging in Breast Neoplasm Female in 133,065 participants. Completed in 31 December 2015.

Timeline
7 July 1977
Primary endpoint
9 September 1986
31 December 2015

Quick facts

Lead sponsorDalarna County Council, Sweden
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposescreening
Enrollment133,065
Start date7 July 1977
Primary completion9 September 1986
Estimated completion31 December 2015

Drugs / interventions tested

Conditions studied

Sponsor

Dalarna County Council, Sweden

Who can join

Adults 40 to 74, female only, with Breast Neoplasm Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Population-based randomized controlled trial carried out in two Swedish counties, Dalarna and Ostergotland to find out the impact of early detection on mortality from breast cancer.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Imaging

Trials testing the same drug.

Other recruiting trials for Breast Neoplasm Female

Currently open trials in the same condition.

Other Dalarna County Council, Sweden trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03217539.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing